NYPOZI (filgrastim-txid)

**Product type:** Human Prescription Drug

**Active ingredient:** FILGRASTIM

**Strength:** 480 ug/480ug

**Dosage form:** Injection

**Route:** Intravenous; Subcutaneous

**Labeler:** Cipla USA Inc.

**Marketing category:** BLA (BLA761126)

**Pharmacologic class:** Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]